Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites.
about
Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imagingMetabolic perturbations of kidney and spleen in murine cerebral malaria: (1)H NMR-based metabolomic studyToward an integrative understanding of social phobiaDelayed hippocampal effects from a single exposure of prepubertal guinea pigs to sub-lethal dose of chlorpyrifos: a magnetic resonance imaging and spectroscopy studyBrain biochemistry and personality: a magnetic resonance spectroscopy studyProton magnetic resonance spectroscopy: technique for the neuroradiologist.Magnetic resonance imaging and magnetic resonance spectroscopy in dementiasVarious MRS application tools for Alzheimer disease and mild cognitive impairment.Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.Value of (1)H-MRS using different echo times in neonates with cerebral hypoxia-ischemia.Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.The bioenergetic status relates to dopamine neuron loss in familial PD with PINK1 mutationsImproved myo-inositol detection through Carr-Purcell PRESS: a tool for more sensitive mild cognitive impairment diagnosis.Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampusElevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrationsNeurochemical abnormalities in anterior cingulate cortex on betel quid dependence: a 2D (1)H MRS investigation.Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopySubclinical vascular disease and cerebral glutamate elevation in metabolic syndrome.Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: clinical and biochemical considerations.Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopyRelationship between changes in brain MRI and (1)H-MRS, severity of chronic liver damage, and recovery after liver transplantation.Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.HRMAS 1H-NMR measured changes of the metabolite profile as mesenchymal stem cells differentiate to targeted fat cells in vitro: implications for non-invasive monitoring of stem cell differentiation in vivo.Which pulse sequence is optimal for myo-inositol detection at 3T?Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy.Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study.Association between altered neurochemical metabolites and apathy in patients with Alzheimer's disease.Application of magnetic resonance spectroscopy in geriatric mood disorders.Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.Brain metabolism in minimal hepatic encephalopathy assessed by 3.0-Tesla magnetic resonance spectroscopy.Glutamatergic and neurometabolic alterations in chronic cocaine users measured with (1) H-magnetic resonance spectroscopy.Altered neurochemical metabolites in Alzheimer's disease patients with unawareness of deficits.Androgen receptor activation results in metabolite signatures of an aggressive prostate cancer phenotype: an NMR-based metabonomics studyMetabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A H MRS StudyVascular Functions and Brain Integrity in Midlife: Effects of Obesity and Metabolic Syndrome
P2860
Q27027307-1E504C63-0194-4F19-AFA8-7B98ACAE8882Q27308064-575F8C15-E990-4D25-9D3E-3BF910634791Q28366405-0BA4B02F-D7A9-4AC4-8181-47398CAD4546Q28383723-49AB4D80-389C-4514-91A8-7748C7893712Q28477785-82DB96A7-3B03-4E13-B73A-13329B5FB483Q30660397-D3EADDCF-F1A3-4CC4-BA3D-23FE128A39C1Q30660816-DC3C15B2-BA15-4BB8-8C52-B80784B9CA66Q30803093-D46B0E47-9347-4E09-AA3D-555F99B1F3E8Q30995022-0C24CBEE-6DE7-4A82-AC42-31725C7B3022Q31032734-4F8F52DF-AC97-46BA-9FF8-3B3C2EAEBCD3Q32067143-7AE67D92-F045-4A55-98C5-4B1B40E0BC1CQ33536778-AAF0414E-3416-41B6-923A-F4DAEAFC8AA2Q33908187-798D51A1-26BD-42AA-B0C7-81A08A1916AFQ34516419-6A90765E-B55D-4881-92AF-F830FFF98B15Q35038099-9C9B0DE2-A717-4462-817E-B2BB3ABA495CQ35752442-33F28F9D-A1DE-4208-A0EF-144B1BDBA037Q36123660-48253CEF-50E4-49E1-8CA6-5AE104005B43Q36209987-ED427E4A-FB9B-4982-8271-04135C2D6BB8Q36516729-CB819A1F-83D9-4470-A76E-CC201F8269C2Q36577038-59C29C25-C08C-4CFE-B9FC-777562302FC3Q36733926-D956BCBB-B1BB-4298-8C7F-8C980B33FEF2Q36826473-33F54FBC-3BE0-4AA0-A99E-2E5822E7E240Q37073878-C2C39C49-C792-4784-85A6-2D0BA3C52A19Q37733519-8AF3ABA9-968A-4222-AF5D-C6583FA9AEBDQ38475793-8E4D4A3F-2BC2-4012-B992-8BF86BD5B943Q41767657-472504FD-918F-425A-8A2A-F631BAB4C542Q41808736-EE0D5E3A-8F91-4030-99F6-63EE76614A0AQ43811264-FDEC537B-8DF2-42F8-B3C3-29DB9A4E5ED3Q44117285-8A7BC45A-1318-492D-8831-E1A7B83DADFDQ46523110-6747DE05-E247-492F-BE2F-6B3ACE3E37A7Q47306994-07E08858-9084-46A3-A3EF-FCA8113DC07AQ47376681-AFE6C0E1-2BC6-4080-AB9E-05824000AC99Q48219698-D503C28E-FB05-488E-8E9D-4EC11D4B58F0Q48244611-7CD3E796-EA03-4163-B45A-CD7C598929CAQ48369960-6EE88356-6582-49B9-BD76-B58F7B8D0A99Q48840735-6D5FA64B-DC7B-4CE4-A646-D426C9CF7CD2Q57975868-16D10388-AA0A-4C85-A29C-CAD274813B95Q58694844-932FDA0A-FD5E-4DD6-828C-1B1687E6785CQ59050557-6EC8CCCF-393F-4E1A-9DC8-0954CDAF3959
P2860
Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites.
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Biochemical considerations in ...... sitol and related metabolites.
@ast
Biochemical considerations in ...... sitol and related metabolites.
@en
type
label
Biochemical considerations in ...... sitol and related metabolites.
@ast
Biochemical considerations in ...... sitol and related metabolites.
@en
prefLabel
Biochemical considerations in ...... sitol and related metabolites.
@ast
Biochemical considerations in ...... sitol and related metabolites.
@en
P356
P1433
P1476
Biochemical considerations in ...... sitol and related metabolites.
@en
P2093
P356
10.1002/NBM.1940040205
P577
1991-04-01T00:00:00Z